• Schedule 13D/G History

INTRACOASTAL CAPITAL, LLC - Significant Ownership

Signature - Title
Intracoastal Capital LLC - Mitchell P. Kopin, Manager
Location
Delray Beach, FL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by INTRACOASTAL CAPITAL, LLC.

Significant Ownership of INTRACOASTAL CAPITAL, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LUCY Innovative Eyewear, Inc. Common stock, par value $0.00001 per share 9.99% $946K 333K Mitchell P. Kopin Apr 11, 2025
PHIO Phio Pharmaceuticals Corp. Common stock, par value $0.0001 per share 9.99% $716K 530K Mitchell P. Kopin Jan 13, 2025
ADD Color Star Technology Co., Ltd. Class A Ordinary Shares, par value $0.0001 per share 9.99% $504K 504K Mitchell P. Kopin Jan 21, 2025
MBIO Mustang Bio, Inc. Common stock, par value $0.0001 per share 9.99% $261K 187K Mitchell P. Kopin Feb 5, 2025
American Rebel Holdings, Inc. Common stock, par value $0.001 per share 9.99% 140K Mitchell P. Kopin Apr 8, 2025
PharmaCyte Biotech, Inc. Common Stock, $0.0001 par value per share 9.99% 715K Mitchell P. Kopin Dec 31, 2024
MBOT Microbot Medical Inc. Common stock, par value $0.01 per share 8.8% $4.09M 2.67M Mitchell P. Kopin Jan 6, 2025
NAYA NAYA Biosciences Inc. Common stock, par value $0.0001 per share 6.9% $166K 504K Mitchell P. Kopin Jan 12, 2025
DRMA Dermata Therapeutics, Inc. Common stock, par value $0.0001 per share 6.7% $320K 262K Mitchell P. Kopin Jan 23, 2025
SVRE SaverOne 2014 Ltd. Ordinary shares, par value NIS 0.01 per share 4.99% $11.3M 35.5M Mitchell P. Kopin Jan 30, 2025
BLRX BioLineRx Ltd. Ordinary shares, par value NIS 0.10 per share 4.99% $11.2M 102M Mitchell P. Kopin Jan 6, 2025
VVOS Vivos Therapeutics Inc. Common stock, par value $0.0001 per share 4.99% $934K 297K Mitchell P. Kopin Dec 22, 2024
GXAI Gaxos.ai Inc. Common stock, par value $0.0001 per share 4.99% $440K 364K Mitchell P. Kopin Dec 26, 2024
LFWD Lifeward Ltd. Ordinary shares, par value NIS 1.75 per share 4.99% $354K 554K Mitchell P. Kopin Jan 7, 2025
SLXN Silexion Therapeutics Corp Ordinary shares, par value $0.0009 per share 4.99% $269K 210K Mitchell P. Kopin Jan 15, 2025
GRI GRI Bio, Inc. Common stock, par value $0.0001 per share 4.99% $241K 40.3K Mitchell P. Kopin Apr 1, 2025
ATNF 180 Life Sciences Corp. Common stock, par value $0.0001 per share 4.99% $187K 165K Mitchell P. Kopin Dec 27, 2024
SXTP 60 Degrees Pharmaceuticals, Inc. Common stock, par value $0.0001 per share 4.99% $174K 387K Mitchell P. Kopin Feb 5, 2025
ENVB Enveric Biosciences, Inc. Common stock, par value $0.01 per share 4.99% $170K 104K Mitchell P. Kopin Jan 30, 2025
LIXT Lixte Biotechnology Holdings, Inc. Common stock, par value $0.0001 per share 4.99% $155K 139K Mitchell P. Kopin Feb 11, 2025
VERO Venus Concept Inc. Common stock, par value $0.0001 per share 2.6% $105K 37.8K Mitchell P. Kopin Apr 9, 2025
APVO Aptevo Therapeutics Inc. Common stock, par value $0.001 per share 0% $0 0 Mitchell P. Kopin Apr 3, 2025
DATS DatChat, Inc. Common stock, par value $0.0001 per share 0% $0 0 Mitchell P. Kopin Jan 8, 2025

Schedules 13D/G Reported by INTRACOASTAL CAPITAL, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.